Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Sagimet Biosciences Inc (SGMT)

120 + Investors. Track Smart Money conviction in SGMT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +36
Streak
1Q ▲
Buyers last Q
73%

Smart Money Signals — SGMT

Based on 122 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added SGMT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
122 hedge funds hold SGMT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +85% more funds vs a year ago

fund count last 6Q
+56 new funds entered over the past year (+85% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 73% buying

95 buying35 selling
Last quarter: 95 funds were net buyers (59 opened a brand new position + 36 added to an existing one). Only 35 were sellers (12 trimmed + 23 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+43 vs last Q)

new funds entering per quarter
Funds opening a new SGMT position: 21 → 27 → 16 → 59. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 25% long-term, 50% new

■ 25% conviction (2yr+) ■ 25% medium ■ 50% new
Of the 122 current holders: 30 (25%) held >2 years, 31 held 1–2 years, and 61 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +459% but shares only +273% — price-driven

Value
+458%
Shares
+273%
Last quarter: the total dollar value of institutional holdings rose +459%, but actual share count only changed +273%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

24 → 21 → 27 → 16 → 59 new funds/Q
New funds entering each quarter: 21 → 27 → 16 → 59. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 40% veterans vs 46% newcomers

■ 40% veterans ■ 14% 1-2yr ■ 46% new
Entry-cohort mix of 127 holders: 51 (40%) are 2+ year veterans, 18 entered 1–2 years ago, and 58 (46%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 30% AUM from major funds

30% from top-100 AUM funds
34 of 121 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.0
out of 10
Moderate Exit Risk
Exit risk score 5.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SGMT

In 2026 Q2, 95 hedge funds were net buyers of SGMT (59 opened a new position, 36 added to an existing one), while 35 reduced or exited (12 trimmed, 23 sold completely) — a 73% buyer ratio, indicating clear institutional accumulation. 30% of total institutional value in SGMT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +36 funds (more new holders than closures). Total institutional holders: 122.

Hedge Fund Ownership: SGMT

How many hedge funds hold SGMT — quarterly history vs. share price
Quarterly hedge fund ownership of SGMT vs. share price

Market Analysis: SGMT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SGMT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Sagimet Biosciences Inc (SGMT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SGMT has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 45d ago
SGMT
+5.2%
XLV
+11.8%

SGMT outperformed XLV by -6.6% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 0d ago
SGMT
+0.0%
XLV
+0.0%

Since the filing became public, SGMT outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

12 top-rated funds 4 high-conviction
Consensus
4.8
/ 10
breadth
×
Elite
3.7
/ 10
conviction
Hedge Fund Positioning: SGMT
2026 Q3 Stats Unlock in 5 days 120 + Investors

Track Smart Money conviction in SGMT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 120 86 39.53%
13F Shares 51M 14M 272.91%
Total Value $395M $71M 457.78%
New Positions 58 16 +42
Increased Positions 35 32 +3
Closed Positions 23 17 +6
Reduced Positions 10 18 -8
Total Calls 3 3 -
Total Puts 3 2 50.0%
PUT/CALL Ratio 1.0 0.67 Neutral

Statistics: SGMT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

120 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SGMT. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 SGMT holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Silverarc Capital Management, LLC 4.33% 3,745,990 $37.0M
2 Blue Owl Capital Holdings LP 2.03% 1,125,544 $11.1M
3 Jones Hill Capital LP 0.84% 502,587 $5.0M
4 ACT Capital Partners, L.P. 0.39% 60,000 $593K
5 Persistent Asset Partners Ltd 0.14% 52,677 $520K
6 T3 Companies, LLC 0.10% 10,700 $106K
7 1492 Capital Management LLC 0.05% 15,000 $148K
8 Federated Hermes, INC. 0.04% 3,093,603 $30.6M
9 RPG Investment Advisory, LLC 0.03% 17,350 $171K
10 Inspire Investing, LLC 0.03% 62,477 $617K
11 Abacus Planning Group, Inc. 0.02% 18,064 $178K
12 Axq Capital, LP 0.01% 10,694 $106K
13 WINTON GROUP Ltd 0.01% 20,000 $198K
14 Profund Advisors LLC 0.01% 19,737 $195K
15 China Universal Asset Management Co., Ltd. 0.01% 11,238 $105K
16 Jasper Ridge Partners, L.P. 0.00% 12,865 $127K
17 Composition Wealth, LLC 0.00% 21,376 $211K
18 Chesapeake Asset Management LLC 0.00% 340 $3K
19 Kestra Advisory Services, LLC 0.00% 66,414 $656K
20 Fulcrum Asset Management LLP 0.00% 4,018 $37K
21 Ameritas Investment Partners, Inc. 0.00% 5,333 $53K
22 Rafferty Asset Management, LLC 0.00% 54,836 $542K
23 Police & Firemen's Retirement System of New Jersey 0.00% 17,331 $171K
24 Renaissance Technologies LLC 0.00% 89,700 $886K
25 Vanguard Fiduciary Trust Co 0.00% 425,613 $4.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Sagimet Biosciences Inc (SGMT)

What does the Smart Money Trend signal show for SGMT?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added SGMT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for SGMT?

More buyers than sellers — 73% buying: Last quarter: 95 funds were net buyers (59 opened a brand new position + 36 added to an existing one). Only 35 were sellers (12 trimmed + 23 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for SGMT holders?

Strong quality — 30% AUM from major funds: 34 of 121 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held SGMT?

Mixed — 25% long-term, 50% new: Of the 122 current holders: 30 (25%) held >2 years, 31 held 1–2 years, and 61 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Sagimet Biosciences Inc (SGMT) following the 2026 Q3 hedge fund 13F filings?

As of today, SGMT has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), SGMT has gained +5.2% vs +11.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →